{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:01:14Z","timestamp":1780617674754,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Natural Science Foundation Project","award":["2023GXNSFAA026053"],"award-info":[{"award-number":["2023GXNSFAA026053"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC81360220"],"award-info":[{"award-number":["NSFC81360220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48419-0","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:46:04Z","timestamp":1776167164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The value of multiparametric magnetic resonance imaging in the prognostic judgment of prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Yanyan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XingQing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiuYing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-yuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"3","key":"48419_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"48419_CR2","first-page":"203","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L. et al. Cancer statistics, 2024. CA Cancer J. Clin. 74(2), 203 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"48419_CR3","doi-asserted-by":"publisher","first-page":"e071082","DOI":"10.1136\/bmj-2022-071082","volume":"381","author":"A Vickers","year":"2023","unstructured":"Vickers, A. et al. Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit. BMJ 381, e071082 (2023).","journal-title":"BMJ"},{"issue":"1","key":"48419_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eururo.2017.08.018","volume":"73","author":"R Faria","year":"2018","unstructured":"Faria, R. et al. Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS). Eur. Urol. 73(1), 23\u201330 (2018).","journal-title":"Eur. Urol."},{"issue":"3","key":"48419_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.eururo.2018.05.035","volume":"75","author":"AR Padhani","year":"2019","unstructured":"Padhani, A. R. et al. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 status update and future directions. Eur. Urol. 75(3), 385\u2013396 (2019).","journal-title":"Eur. Urol."},{"issue":"3","key":"48419_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey, B. et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur. Urol. 76(3), 340\u2013351 (2019).","journal-title":"Eur. Urol."},{"issue":"1","key":"48419_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey, P. A. et al. The 2016 WHO classification of tumours of the urinary system and male genital organs - Part B: prostate and bladder tumours. Eur. Urol. 70(1), 106\u2013119 (2016).","journal-title":"Eur. Urol."},{"issue":"4","key":"48419_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.eururo.2015.10.040","volume":"69","author":"MA Rubin","year":"2016","unstructured":"Rubin, M. A., Girelli, G. & Demichelis, F. Genomic correlates to the newly proposed grading prognostic groups for prostate cancer. Eur. Urol. 69(4), 557\u2013560 (2016).","journal-title":"Eur. Urol."},{"issue":"2","key":"48419_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2021","unstructured":"Cornford, P. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur. Urol. 79(2), 263\u2013282 (2021).","journal-title":"Eur. Urol."},{"issue":"2","key":"48419_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMe1103829","volume":"365","author":"AV D\u2019Amico","year":"2011","unstructured":"D\u2019Amico, A. V. Risk-based management of prostate cancer. N. Engl. J. Med. 365(2), 169\u2013171 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"48419_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.euf.2017.02.017","volume":"4","author":"PJ Lamy","year":"2018","unstructured":"Lamy, P. J. et al. Prognostic biomarkers used for localised prostate cancer management: A systematic review. Eur. Urol. Focus 4(6), 790\u2013803 (2018).","journal-title":"Eur. Urol. Focus"},{"issue":"2","key":"48419_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur. Urol. 79(2), 243\u2013262 (2021).","journal-title":"Eur. Urol."},{"issue":"4","key":"48419_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.euo.2022.09.005","volume":"6","author":"M Baboudjian","year":"2023","unstructured":"Baboudjian, M. et al. Magnetic resonance imaging-based T-staging to predict biochemical recurrence after radical prostatectomy: a step towards the iTNM classification. Eur. Urol. Oncol. 6(4), 406\u2013413 (2023).","journal-title":"Eur. Urol. Oncol."},{"issue":"12","key":"48419_CR14","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.21037\/qims-22-184","volume":"12","author":"APM Walker","year":"2022","unstructured":"Walker, A. P. M. et al. Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging. Quant. Imaging Med. Surg. 12(12), 5309\u20135325 (2022).","journal-title":"Quant. Imaging Med. Surg."},{"issue":"4","key":"48419_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/jmri.26928","volume":"51","author":"I Jambor","year":"2020","unstructured":"Jambor, I. et al. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score. J. Magn. Reson. Imaging 51(4), 1075\u20131085 (2020).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"48419_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/JU.0000000000001821","volume":"206","author":"P Rajwa","year":"2021","unstructured":"Rajwa, P. et al. The prognostic association of prostate MRI PI-RADS\u2122 v2 assessment category and risk of biochemical recurrence after definitive local therapy for prostate cancer: A systematic review and meta-analysis. J. Urol. 206(3), 507\u2013516 (2021).","journal-title":"J. Urol."},{"issue":"1","key":"48419_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jmri.25539","volume":"46","author":"CS Lim","year":"2017","unstructured":"Lim, C. S. et al. Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy. J. Magn. Reson. Imaging 46(1), 257\u2013266 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"2","key":"48419_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3348\/kjr.2018.0613","volume":"20","author":"R Kim","year":"2019","unstructured":"Kim, R. et al. Prognostic significance for long-term outcomes following radical prostatectomy in men with prostate cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2. Korean J. Radiol. 20(2), 256\u2013264 (2019).","journal-title":"Korean J. Radiol."},{"issue":"1","key":"48419_CR19","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.1038\/s41598-023-36685-1","volume":"13","author":"A Fujimoto","year":"2023","unstructured":"Fujimoto, A. et al. Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy. Sci. Rep. 13(1), 10079 (2023).","journal-title":"Sci. Rep."},{"key":"48419_CR20","doi-asserted-by":"publisher","first-page":"263417","DOI":"10.1155\/2014\/263417","volume":"2014","author":"SS Anwar","year":"2014","unstructured":"Anwar, S. S. et al. Assessment of apparent diffusion coefficient values as predictor of aggressiveness in peripheral zone prostate cancer: comparison with Gleason score. ISRN Radiol. 2014, 263417 (2014).","journal-title":"ISRN Radiol."},{"issue":"1","key":"48419_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00261-016-0848-y","volume":"42","author":"H Shaish","year":"2017","unstructured":"Shaish, H., Kang, S. K. & Rosenkrantz, A. B. The utility of quantitative ADC values for differentiating high-risk from low-risk prostate cancer: A systematic review and meta-analysis. Abdom. Radiol. (NY) 42(1), 260\u2013270 (2017).","journal-title":"Abdom. Radiol. (NY)"},{"issue":"2","key":"48419_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein, J. I. et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am. J. Surg. Pathol. 40(2), 244\u2013252z (2016).","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"48419_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu, H. User\u2019s guide to correlation coefficients. Turk. J. Emerg. Med. 18(3), 91\u201393 (2018).","journal-title":"Turk. J. Emerg. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48419-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48419-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48419-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:03:16Z","timestamp":1780614196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48419-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48419"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48419-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of The First Affiliated Hospital of Guangxi Medical University (ethics approval number: 2024-E791-01), and written informed consent was waived due to the retrospective nature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"17424"}}